U.S. markets closed

  • S&P Futures

    4,375.50
    -1.00 (-0.02%)
     

  • Dow Futures

    34,882.00
    +7.00 (+0.02%)
     

  • Nasdaq Futures

    14,880.25
    +11.00 (+0.07%)
     

  • Russell 2000 Futures

    2,274.10
    -3.20 (-0.14%)
     

  • Crude Oil

    74.32
    +0.22 (+0.30%)
     

  • Gold

    1,811.20
    +5.30 (+0.29%)
     

  • Silver

    26.40
    +0.16 (+0.61%)
     

  • EUR/USD

    1.1878
    +0.0011 (+0.10%)
     

  • 10-Yr Bond

    1.3630
    +0.0070 (+0.52%)
     

  • Vix

    16.17
    -0.01 (-0.06%)
     

  • GBP/USD

    1.3904
    +0.0020 (+0.14%)
     

  • USD/JPY

    110.3760
    +0.0280 (+0.03%)
     

  • BTC-USD

    33,209.61
    -1,222.97 (-3.55%)
     

  • CMC Crypto 200

    810.43
    -35.21 (-4.16%)
     

  • FTSE 100

    7,125.42
    +3.54 (+0.05%)
     

  • Nikkei 225

    28,792.06
    +223.04 (+0.78%)
     
Webinar:

Yahoo Finance Plus presents 'How to invest in meme stocks while managing trading risk'

Michele Schneider joins Jared Blikre to talk momentum trades and advanced charting on Wed, 7/14 at 2PM EDT

Global Cancer Diagnostic Devices Market | Analyzing Growth in Health Care Equipment Industry | Emerging Trends, Company Risk, and Key Executives| Technavio

·4 min read

NEW YORK, July 12, 2021 /PRNewswire/ -- The cancer diagnostic devices market is poised to grow by USD 6.05 billion during 2021-2025, progressing at a CAGR of almost 8% during the forecast period.

Technavio has announced its latest market research report titled Cancer Diagnostic Devices Market by Product and Geography - Forecast and Analysis 2021-2025
Technavio has announced its latest market research report titled Cancer Diagnostic Devices Market by Product and Geography - Forecast and Analysis 2021-2025

Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get a FREE Sample Report Now!

The report on the cancer diagnostic devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the high prevalence of cancer.

The cancer diagnostic devices market analysis includes the product segment and geographic landscape. This study identifies the need for cost-cutting in drug discovery and development as one of the prime reasons driving the cancer diagnostic devices market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The cancer diagnostic devices market covers the following areas:

Cancer Diagnostic Devices Market Sizing
Cancer Diagnostic Devices Market Forecast
Cancer Diagnostic Devices Market Analysis

Download the free sample report here: www.technavio.com/talk-to-us?report=IRTNTR70692

Companies Mentioned

  • Abbott Laboratories

  • Agilent Technologies Inc.

  • Becton, Dickinson and Co.

  • bioMerieux SA

  • F. Hoffmann-La Roche Ltd.

  • Hologic Inc.

  • Illumina Inc.

  • Myriad Genetics Inc.

  • QIAGEN NV

  • Thermo Fisher Scientific Inc.

Related Reports on Health Care Include:
Global Lung Cancer Liquid Biopsy Market - Global lung cancer liquid biopsy market is segmented by product (CTCs and ctDNA and Exosomes and RNA) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report

Global Pathology Instruments Market - Global pathology instruments market is segmented by application (diagnostics, drug discovery, and other applications) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2020

  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Product

  • Market segments

  • Comparison by Product

  • Molecular diagnostics - Market size and forecast 2020-2025

  • Companion diagnostics - Market size and forecast 2020-2025

  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2020-2025

  • Europe - Market size and forecast 2020-2025

  • Asia - Market size and forecast 2020-2025

  • ROW - Market size and forecast 2020-2025

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Overview

  • Vendor landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Abbott Laboratories

  • Agilent Technologies Inc.

  • bioMerieux SA

  • F. Hoffmann-La Roche Ltd.

  • Hologic Inc.

  • Illumina Inc.

  • Myriad Genetics Inc.

  • QIAGEN NV

  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Report: www.technavio.com/report/cancer-diagnostic-devices-market-industry-analysis
Newsroom: newsroom.technavio.com/news/cancer-diagnostic-devicesmarket

Technavio (PRNewsfoto/Technavio)
Technavio (PRNewsfoto/Technavio)
Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/global-cancer-diagnostic-devices-market--analyzing-growth-in-health-care-equipment-industry--emerging-trends-company-risk-and-key-executives-technavio-301328793.html

SOURCE Technavio

Recommended Stories

  • New Zealand May Open Rate-Hike Door Amid Signs Economy Is Overheating

    (Bloomberg) -- New Zealand’s central bank may signal it’s willing to begin tightening monetary policy later this year as a slew of strong data suggest the economy is overheating.The Reserve Bank will leave the official cash rate at 0.25% at its review Wednesday in Wellington, according to all 24 analysts surveyed by Bloomberg. But economists at the country’s four largest banks now predict the RBNZ will start raising rates in November, and they expect it to tacitly acknowledge that possibility in

  • Salon owner in Connecticut sells business to ‘worthy’ employee for just $1

    Salon owner Pio Imperati took a chance and hired hairstylist Kathy Moura right out of technical high school 15 years ago. It has worked out so well that Imperati sold her his venerable New Haven, Conn., business for $1.

  • Musk tells SolarCity trial that Tesla would 'die' if he wasn't CEO

    Elon Musk insisted in court that Tesla Inc's board controls the company but also said the electric vehicle maker would "die" if he wasn't the chief executive, as he ended his first day of testimony on Monday in defense of Tesla's 2016 acquisition of SolarCity. The lawsuit by union pension funds and asset managers alleges the celebrity CEO strong-armed Tesla's board of directors into depleting the company’s assets with the $2.6 billion all-stock deal for SolarCity. The CEO at the time owned a roughly 22% stake in both Tesla and SolarCity, which was founded by his cousins, and some Tesla shareholders alleged the deal was aimed at bailing out Musk's investment in the solar panel company.

  • Theater chains in ‘deep trouble’ despite post-pandemic box office record: Greenfield

    LightShed Partners’ Rich Greenfield discusses the weekend’s record post-pandemic box office performance, and why he thinks movie theater chains are in real trouble. With AMC specifically, he explains why he thinks the company will eventually shrink as people continue to buy shares for uneconomic reasons.

  • From Google to Roblox, How One Young Tech Worker Is Building Her Dream Career

    At 26, Andrea Fletcher has worked for Google, Apple and Roblox but says her career in software engineering really began with her childhood love of logic and math puzzles.

  • China’s Anta is about to become more valuable than Adidas

    At the current rate, Anta will soon overtake Adidas as the second-most valuable sports company in the world, trailing only Nike.

  • Oil Edges Higher as Investors Assess Uncertain Demand Outlook

    (Bloomberg) -- Oil edged higher after falling for the first time in three days as the market assessed the outlook for energy demand following the latest Covid-19 comeback across the world.Futures in New York added 0.2% after sliding 0.6% on Monday to settle near $74 a barrel. The delta variant is spreading rapidly through regions from Asia to the U.S., leading to a spike in infections and renewed lockdowns. The flare-up adds to market uncertainty after OPEC+ ended supply talks last week without

  • Airline Earnings Are Coming. Wall Street Is Getting Bearish.

    Delta Air Lines kicks off the reporting season on Wednesday. The sector's outlook is darkening as the Delta variant spreads and jet fuel prices jump.

  • Ignoring This Conventional Advice Could Save You on Taxes in Retirement

    Many retirees paying almost no tax early in retirement then get hit with stiff tax bills in their 70s after they start collecting Social Security and begin required distributions.

  • Introduction to Social Security

    The Social Security system is funded through payroll taxes. Contrary to popular belief, this money is not put in trust for the individual employees who are paying into the system but is pooled and used to pay existing retirees. Eligibility for Social Security benefits is accrued over time.

  • Exela Technologies Expands AI Automation Offering

    Business process automation (BPA) company Exela Technologies, Inc (NASDAQ: XELA) expanded its AI-enabled automation offering in the BPA space with Intelligent Document Processing (IDP) combined with its robotic process automation platform (EON). IDP enables the automation of document classification, data extraction, and data routing into a cloud or on-premise hosted service portal that provides a containerized, dynamically scaling solution accessible from anywhere on-demand. Using the IDP system

  • U.S. oil mergers surge as energy, share prices recover from pandemic

    U.S. oil and gas mergers surged last quarter with the most $1 billion plus combinations since 2014, according to data released on Monday, as rising energy and share prices led to larger oilpatch deals. Producer are consolidating in U.S. shale as oil and natural gas prices recover from last year's pandemic swoon and this month traded at multi-year highs. Smaller producers also are snapping up unwanted properties in a bet on continued demand for oil and gas while some big oil companies shift their acquisition emphasis to renewables.

  • Apple’s win in Blix case comes weeks before Epic decision

    Blix, which lost to Apple for the second time since December, is one of the founding members of Coalition for App Fairness. One of the group's other founding members, Epic Games Inc., awaits a federal judge's decision in its antitrust lawsuit vs. Apple and the App Store.

  • Is Exxon Stock A Buy As Climate Change Activists To Join Board?

    An activist investor won at least three seats on Exxon Mobil's board, upending the oil major's climate change approach. Is Exxon stock a good buy?

  • Taiwan can finally access BioNTech jabs in what might be the world’s most complicated vaccine deal

    Two of Taiwan’s largest corporations have intervened to break a monthslong stalemate over the doses.

  • Analysis - Big Oil keeps brakes on spending even with crude rally windfall

    Leading international energy companies are resisting the temptation to rush and spend an unexpected windfall from rallying oil and natural gas prices as they focus on longer-term energy transition challenges, executives and analysts said. That, along with higher global natural gas prices because of supply issues, will boost the coffers of oil companies after firms like Exxon Mobil, Royal Dutch Shell and BP sharply cut costs in the wake of the coronavirus pandemic last year. While the heads of top energy companies said last month $100-a-barrel oil was achievable again in coming years, they added prices would be volatile, meaning there is little incentive, at least for now, to commit billions to projects that could take a decade or more to show a return on investment.

  • Exclusive: FAA says new Boeing production problem found in undelivered 787 Dreamliners

    The Federal Aviation Administration (FAA) said late on Monday that some undelivered Boeing 787 Dreamliners have a new manufacturing quality issue that the manufacturer will fix before the planes will be delivered. Boeing did not immediately comment. This is the latest production issue to hit Boeing's troubled 787 Dreamliner.

  • Get Paid While You Wait: 3 Top Dividend Stocks in Semiconductor Manufacturing

    This crucial segment of the economy has some of the best long-term growth prospects, with dividend sweeteners on top.

  • OPEC+ Locks in Tight Supply for August With Stalemate Unresolved

    (Bloomberg) -- One week after OPEC and its allies abandoned their meeting in acrimony, the window for an August oil-production increase is closing without any deal in sight.Regardless of the desire of other cartel members for a compromise, there’s little sign that Saudi Arabia and the United Arab Emirates have made progress in resolving a dispute over how their production cuts are measured, delegates said.Meanwhile, both countries have proceeded to lock in supply volumes for their customers next

  • UPDATE 7-Musk tells SolarCity trial that Tesla would 'die' if he wasn't CEO

    Elon Musk insisted in court that Tesla Inc's board controls the company but also said the electric vehicle maker would "die" if he wasn't the chief executive, as he ended his first day of testimony on Monday in defense of Tesla's 2016 acquisition of SolarCity. The lawsuit by union pension funds and asset managers alleges the celebrity CEO strong-armed Tesla's board of directors into depleting the company’s assets with the $2.6 billion all-stock deal for SolarCity. The CEO at the time owned a roughly 22% stake in both Tesla and SolarCity, which was founded by his cousins, and some Tesla shareholders alleged the deal was aimed at bailing out Musk's investment in the solar panel company.